In his new role leading the Chan Zuckerberg Biohub New York, Andrea Califano will bring together scientists from several universities to engineer the immune system to detect and treat disease.
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
Study of insulin-producing cells derived from skin of diabetes patients shows utility of iPS cells for study of human disease and as potential therapy.
Columbia Magazine reports on an NIH-funded study, led by Dr. Ronald Wapner, where thousands of women were provided microarray, a powerful genetic test, for prenatal testing.
Kevin L. Gardner, MD, PhD, has been named senior vice chair of the Department of Pathology and Cell Biology and professor of pathology and cell biology.